Diagnosis

Ulcer disease

Damage to the digestive tract (stomach or duodenum) with mucosal ruptures greater than 3–5 mm making the submucosa visible.

Also known as: Duodenal ulcer, Gastric ulcer, Peptic ulcer disease

Etiology

Cause [huc]

Pathophysiology

  1. Mucosal injury and peptic ulcer occur when the balance between the aggressive factors and the defensive mechanisms is disrupted

    • Aggresive factors: H.pylori, drug side effects (NSAIDs, SSRIs, corticosteroids, and anticoagulants), bile salts, smoking, alcohol, Zollinger-Ellison syndrome

    • Defensive mechanisms: bicarbonate secretion, mucus, mucosal blood flow, epithelial renewal

  2. Once the protective superficial mucosal layer is damaged, the inner layers are susceptible to acidity

  3. Helicobacter Pylori --> mucosal inflammation and host tissue damage

  4. NSAIDs --> inhibit COX-enzyme --> block prostaglandin synthesis --> decreased gastric mucus and bicarbonate production and a decrease in mucosal blood flow

  5. Alcohol --> irritate the gastric mucosa and induce acidity

  6. Hypersecretion of acid:

    • Zollinger Ellison syndrome

    • Systemic mastocytosis

    • Cystic fibrosis

    • Hyperparathyroidism

    • Antral G cell hyperplasia

  7. Clinical manifestation:

    • Epigastric abdominal pain

    • Bloating/dysphagia

    • Abdominal fullness

    • Nausea and vomiting

    • Weight loss/weight gain

    • Hematemesis

    • Melena

Complications [huc]

Epidemiology

Incidence per 100.000 [wz9][gt9][onf][ygn][9pi][yyw][8an][9p6]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Anorexia, Belching, Bloating, Dizziness, Dysphagia, Heartburn, Hematemesis, Hematochezia, Loss of appetite, Melena, Nausea, Odynophagia, Syncope, Vomiting, Weight loss

Clinical findings

Anemia

Anamneses

None listed.

Localized findings

Pain
Radiates
Regio epigastrica
Onset
Subacute (hours)Gradual (days)
Pattern
Intermittent
Provoked by
Postprandial
Quality
BurningGnawing
Severity
Mild (1-3)Moderate (4-7)Severe (8-10)

Approach

Treatment

  1. Lifestyle changes: NSAIDs, smoking, alcohol consumption [huc]

  2. Antisecretory drugs: Proton pump inhibitor (PPI), H2 blocker

  3. Eradication of H.pylori -> triple regimen comprising two antibiotics and a PPI:

    • Pantoprazole, clarithromycin, and metronidazole/amoxicillin for 7 to 14 days

    • If failure to response: Quadruple therapy with bismuth

  4. Surgical treatment: if unresponsive to medical treatment

    • Vagotomy or partial gastrectomy

Differential diagnoses

Acute pancreatitis, Aortic dissection, Arteriovenous malformation, Cholangitis, Cholecystitis, Cholelithiasis, Chronic mesenteric ischemia, Chronic pancreatitis, Colorectal cancer, Crohn disease, Diverticulitis, Drug side effects, Esophageal perforation, Esophageal varices, Esophagitis, Functional dyspepsia, Gastric cancer, Gastritis, Gastroenteritis, Gastroesophageal reflux disease, Gastrointestinal obstruction, Gastrointestinal perforation, Hemobilia, Mallory-Weiss tear, Myocardial infarction, Perforated ulcer, Ruptured aortic aneurysm, Ulcerative colitis, Viral hepatitis, Volvulus, Zollinger-Ellison syndrome


References

[1] Malik TF, Gnanapandithan K, Singh K. Peptic Ulcer Disease. Updated 2023 Jun 5: https://www.ncbi.nlm.nih.gov/books/NBK534792/

[2] Sun J, Huang L, Li R, Wang T, Wang S, Yu C, Gong J. Comparison of Secular Trends in Peptic Ulcer Diseases Mortality in China, Brazil and India during 1990-2019: An Age-Period-Cohort Analysis. Healthcare (Basel). 2023 Apr 11;11(8):1085.

[3] Kurata JH, Nogawa AN, Abbey DE, Petersen F. A prospective study of risk for peptic ulcer disease in Seventh-Day Adventists. Gastroenterology. 1992 Mar;102(3):902-9.

[4] Sung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther. 2009 May 1;29(9):938-46.

[5] Malmi H, Kautiainen H, Virta LJ, Färkkilä N, Koskenpato J, Färkkilä MA. Incidence and complications of peptic ulcer disease requiring hospitalisation have markedly decreased in Finland. Aliment Pharmacol Ther. 2014 Mar;39(5):496-506.

[6] García Rodríguez LA, Hernández-Díaz S. Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Am J Epidemiol. 2004 Jan 1;159(1):23-31.

[7] Pérez-Aisa MA, Del Pino D, Siles M, Lanas A. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2005 Jan 1;21(1):65-72.

[8] Bartholomeeusen S, Vandenbroucke J, Truyers C, Buntinx F. Time trends in the incidence of peptic ulcers and oesophagitis between 1994 and 2003. Br J Gen Pract. 2007 Jun;57(539):497-9.

[9] Kang JY, Tinto A, Higham J, Majeed A. Peptic ulceration in general practice in England and Wales 1994-98: period prevalence and drug management. Aliment Pharmacol Ther. 2002 Jun;16(6):1067-74.

[10] Rosenstock SJ, Jørgensen T. Prevalence and incidence of peptic ulcer disease in a Danish County--a prospective cohort study. Gut. 1995 Jun;36(6):819-24.

[11] http://emedicine.medscape.com/article/181753 (2014-01-02); [Medscape]

[12] Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol. 2006 May;101(5):945-53.

Scroll to top